Related Experiment Videos
Primary genitourinary melanoma
A T Nguyen1, J P Kavolius, P Russo
1Weill Medical College of Cornell University, New York, New York, USA.
Urology
|April 18, 2001
Summary
Genitourinary melanoma is a rare cancer with a poor prognosis. Long-term survival is uncommon, though scrotal melanomas may offer a better outlook for patients.
Area of Science:
- Oncology
- Dermatology
- Urology
Background:
- Genitourinary melanoma is an exceptionally rare malignancy.
- Understanding its clinical presentation and outcomes is crucial for patient management.
Purpose of the Study:
- To detail the presentation, treatment strategies, and clinical outcomes of genitourinary melanoma patients.
- To analyze survival rates and prognostic factors in this rare cancer.
Main Methods:
- Retrospective review of 14 patients diagnosed with genitourinary melanoma.
- Data collection included patient presentation, surgical interventions, disease progression, and survival.
- Survival analysis employed the Kaplan-Meier product limit method.
Main Results:
- Presentation and management approaches for genitourinary melanoma were diverse.
- The overall prognosis was poor, with a median survival of 43 months.
- Only 3 patients achieved disease-free survival at the conclusion of the study.
Conclusions:
- Genitourinary melanoma is a rare disease associated with a significantly unfavorable clinical outcome.
- Long-term survival is observed in less than one-third of affected individuals.
- Scrotal melanomas might present a comparatively better prognosis.